WGRX (WGRX)
Wellgistics Health, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 2.51M shares outstanding
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies.
Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise.
The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies.
It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Leadership
Shafaat Pirani
Chief Clinical Officer
Srini Kalla
Chief Technology Officer
Eric Michael Sherb
Interim-CFO
Prashant Patel
Interim Co-CEO, President & Director
Employees
31
Country
US
Sector
Healthcare
Website
wellgisticshealth.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chief Executive Officer | In-the-Money Exercise | 100.0K | $500 | Jun 22, 2026 | |
| Chief Executive Officer | In-the-Money Exercise | 100.0K | -- | Jun 22, 2026 | |
| Director | In-the-Money Exercise | 100.0K | -- | Jun 22, 2026 | |
| Director | In-the-Money Exercise | 100.0K | $500 | Jun 22, 2026 | |
| Chief Executive Officer | Grant/Award | 5.00M | $1.00M | Mar 31, 2026 | |
| Director | Grant/Award | 5.00M | $500 | Mar 31, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Patel Prashant Chief Executive Officer, Director | 282.4K | 11.2% | FORM 4 |
AJJARAPU SURENDRA K Director | 257.6K | 10.3% | FORM 4 |
Norton Brian Chief Executive Officer | 180.9K | 7.2% | FORM 4 |
JANE STREET GROUP, LLC | 20.5K | 0.8% | 13F |
GEODE CAPITAL MANAGEMENT, LLC | 12.5K | 0.5% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 11.1K | 0.4% | 13F |
VANGUARD FIDUCIARY TRUST CO | 6.2K | 0.2% | 13F |
Kalla Srinivas Chief Information Officer | 5.9K | 0.2% | FORM 4 |
Panchal Nikul Chief Pharmacy Officer | 5.7K | 0.2% | FORM 4 |
ANDERSON DONALD WILLIAM Director | 4.9K | 0.2% | FORM 4 |
Insiders
- Patel PrashantChief Executive Officer
- AJJARAPU SURENDRA KDirector
- PETERSON MICHAEL LDirector
- ANDERSON DONALD WILLIAMDirector
- Norton BrianChief Executive Officer
- Panchal NikulChief Pharmacy Officer
- SHANAHAN REBECCA MDirector
- Syed SajidDirector
- Pirani ShafaatChief Clinical Officer
- Kalla SrinivasChief Information Officer
based on 2.51M shares outstanding
30d Avg
--
60d Avg
--
90d Avg
--